$127.64 $1.59 (1.3%)

04:00 PM EDT on 08/21/19

Zoetis Inc Cl A (NYSE:ZTS)

CAPS Rating: 5 out of 5

Current Price $127.64 Mkt Cap $59.4B
Open $126.84 P/E Ratio 0.00
Prev. Close $126.05 Div. (Yield) $0.66 (0.6%)
Daily Range $126.23 - $128.13 Volume 303,143
52-Wk Range $81.37 - $128.41 Avg. Daily Vol. 40

Caps

How do you think NYSE:ZTS will perform against the market?

Add Stock to CAPS Watchlist

All Players

143 Outperform
5 Underperform
 

All-Star Players

33 Outperform
0 Underperform
 

Wall Street

7 Outperform
0 Underperform
 

Top NYSE:ZTS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFBlacknGold (94.76)
Submitted December 21, 2018

From 12/17/2018:"It's not difficult to make a case for the long-term prospects of Zoetis. The company is comfortably profitable, growing at a healthy clip in recession-proof markets, and boasts multiple shots on goal in high-growth opportunities.… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NYSE:ZTS VS S&P 500 (SPY)

Fools bullish on NYSE:ZTS are also bullish on:

Fools bearish on NYSE:ZTS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ZTS.

Recs

1
Member Avatar TMFBlacknGold (94.76) Submitted: 12/21/2018 1:22:59 PM : Outperform Start Price: $28.41 NYSE:ZTS Score: +293.42

From 12/17/2018:

"It's not difficult to make a case for the long-term prospects of Zoetis. The company is comfortably profitable, growing at a healthy clip in recession-proof markets, and boasts multiple shots on goal in high-growth opportunities. While the growth potential is undeniable, so is the fact that Zoetis stock is very expensive. It trades at 28 times future earnings, 20 times book value, and 21 times enterprise value to EBITDA -- all significantly higher than its more traditional pharmaceutical peers.

That said, comparing the animal health leader to human-health peers may not make much sense. A more apt comparison is Elanco Animal Health, which just made its debut on the stock markets in summer 2018. However, the smaller peer has a different portfolio mix and, following years of reshuffling assets, is still largely unproven in its current form. Essentially, there aren't any great head-to-head comparisons to make today.

Although the stock is rather expensive, investors who believe in the long-term growth potential of Zoetis may not hesitate to begin building a position in the company, especially if there's a pullback."

https://www.fool.com/investing/2018/12/17/is-it-too-late-to-get-in-on-this-millionaire-maker.aspx

Recs

1
Member Avatar afaithfulsteward (70.14) Submitted: 11/27/2018 2:58:19 PM : Outperform Start Price: $89.65 NYSE:ZTS Score: +33.25

Millennials love their pets. Animal care and diagnostics is a basket I believe has long tail winds.

Recs

0
Member Avatar NHWeston102 (72.39) Submitted: 8/14/2018 12:46:35 PM : Outperform Start Price: $91.22 NYSE:ZTS Score: +36.91

The "humanization of pets" is a major subterranean trend in pharma and it's one that the government won't mess with. (i.e. ZTS is a lot more secure than Medicare or Medicaid.)

Leaderboard

Find the members with the highest scoring picks in ZTS.

Score Leader

ccastineyra

ccastineyra (73.99) Score: +294.25

The Score Leader is the player with the highest score across all their picks in ZTS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Clint35 62.39 3/26/2014 Outperform 5Y $28.25 +351.81% +56.34% +295.47 0 Comment
ccastineyra 73.99 3/19/2014 Outperform 5Y $28.37 +349.98% +55.73% +294.25 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. splintercell62 31.22 3/19/2014 Outperform 3Y $28.38 +349.82% +55.70% +294.12 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. TMFBlacknGold 94.76 3/19/2014 2/21/2019 Outperform 5Y $28.41 +349.21% +55.79% +293.42 1 Comment
themorrobaykid 43.58 3/13/2014 Outperform NS $28.55 +347.10% +55.67% +291.43 0 Comment
sobek1 62.42 3/19/2014 Outperform 5Y $28.54 +347.25% +55.87% +291.38 0 Comment
cyberspoof < 20 2/24/2014 Outperform 5Y $28.61 +346.20% +58.68% +287.52 0 Comment
gatzbp 88.22 5/20/2014 10/12/2018 Outperform 1Y $29.22 +336.89% +56.19% +280.70 0 Comment
dth20k 37.11 6/2/2014 Outperform 5Y $29.66 +330.37% +51.55% +278.82 0 Comment
elyk13 49.54 8/22/2013 Outperform 5Y $28.33 +350.55% +75.92% +274.63 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackStifel 91.40 3/4/2019 Outperform NS $96.86 +31.78% +3.84% +27.94 0 Comment
TrackCharlesPayn < 20 2/13/2015 Outperform 3M $44.04 +189.85% +40.01% +149.84 0 Comment
TrackBMOCapital < 20 1/6/2014 Outperform NS $30.96 +312.33% +59.38% +252.95 0 Comment
TrackBofASec 91.79 7/5/2013 Outperform NS $28.45 +348.64% +79.98% +268.66 0 Comment
TrackArgus 84.45 6/26/2013 Outperform NS $30.35 +320.57% +82.90% +237.66 0 Comment
TrackUltraLong < 20 2/8/2013 Outperform NS $30.78 +314.74% +93.37% +221.38 1 Comment
TrackJimCramer 86.50 2/5/2013 Outperform 3W $29.57 +331.71% +93.58% +238.13 0 Comment